{
  "docId": "019dd923-622c-750b-8b98-08d95731b035",
  "docSlug": "4dea9707af58",
  "documentTitle": "AtriCure, Inc. (ATRC)",
  "authorId": "53_Kerrisdale_Capital",
  "authorName": "Kerrisdale Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2020-09-01 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 17,
  "pageCount": 34,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "other",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "This is a standard text-heavy research report page with bulleted data points and footnotes.",
  "elementsJson": [
    "paragraph",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/17",
  "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-08d95731b035.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.21,
        "x": 0.06,
        "y": 0.03
      },
      "kind": "image",
      "text": "Kerrisdale Capital",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da80e340-ac9e-4f56-948a-41800eecfce6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.77,
        "x": 0.11,
        "y": 0.47
      },
      "kind": "list",
      "text": "The study's primary effectiveness endpoint was defined as freedom from documented AF/AT/AFL episodes of 30 seconds or longer at 15 months... at 12 months, the primary effectiveness was ~68%.\nClinical success... 12-month success rate was ~85%.\nTo make it simpler to compare... single-ablation success rate at 12 months was 73.2%.\nOn the safety front, the primary adverse event rate was 3.8%, well below the 8% seen in CONVERGE.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ba259dc-be5a-49a1-8e3e-ce87358c9fe4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "primary effectiveness: 6",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-64d2-7657-bbed-f227bbe813f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.77,
        "x": 0.11,
        "y": 0.74
      },
      "kind": "paragraph",
      "text": "The PRECEPT results strongly indicate that, even without the systematic ablation of the posterior wall, standard catheter ablation procedures have become quite effective at treating even the more intractable cases of AF...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "008a469e-af1d-4a90-b795-4dfa505cdc8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.77,
        "x": 0.11,
        "y": 0.37
      },
      "kind": "paragraph",
      "text": "The PRECEPT trial gave EPs a large degree of discretion in deciding what to ablate. The only requirement was that a PVI be performed, with non-PV triggers ablated only at the EP's discretion...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b6541121-f32b-4afc-a098-2d66bff29851",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.77,
        "x": 0.11,
        "y": 0.14
      },
      "kind": "paragraph",
      "text": "All of the above studies conducted somewhat \"primitive\" catheter ablation procedures compared to the technology that's available to EPs today, and yet their efficacy rates are broadly similar to those demonstrated by the Convergent arm...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f13f3351-cb7c-4a7c-80b2-5a38bb7da1b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.77,
        "x": 0.11,
        "y": 0.84
      },
      "kind": "source-note",
      "text": "12 Aryana, A, et al, Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f155ad79-a693-448f-85ef-871b4a84e168",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 6,
      "beatId": "4e62a9ca-4c36-4797-a49e-21bad253e137",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle",
      "beatSlug": "overcoming-monster-the-struggle",
      "evidence": "The document presents various critiques of AtriCure's business model and market prospects",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 5,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "ddc2fc5b-a109-4c3d-a59c-6071803a7a20",
      "evidence": "The document presents various critiques of AtriCure's business model and market prospects",
      "position": 0,
      "objective": "To identify patterns in AtriCure's business model and market prospects that indicate a flawed strategy",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}